Cargando…

Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus

The coronavirus disease 2019 (COVID-19) is widely spread and remains a global pandemic. Limited evidence on the systematic evaluation of the impact of treatment regimens on antibody responses exists. Our study aimed to analyze the role of antibody response on prognosis and determine factors influenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Yufeng, Liu, Tao, Li, Jingfeng, Kaweme, Natasha Mupeta, Wang, Xinghuan, Zhou, Fuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082543/ https://www.ncbi.nlm.nih.gov/pubmed/33936026 http://dx.doi.org/10.3389/fimmu.2021.580147

Ejemplares similares

Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)

Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)

The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2020)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: de Miranda Santos, Isabel Kinney Ferreira, et al.
Publicado: (2020)

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China
por: Shang, Yufeng, et al.
Publicado: (2022)

Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: Santos, Isabel Kinney Ferreira De Miranda, et al.
Publicado: (2020)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments
por: Wang, Yingying, et al.
Publicado: (2020)

Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
por: Konwarh, Rocktotpal
Publicado: (2020)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
por: de Souza, Matheus Oliveira, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray
por: Hosseinian, Sina, et al.
Publicado: (2022)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
por: Heinen, Natalie, et al.
Publicado: (2022)

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
por: Schmidt, Katja G., et al.
Publicado: (2021)

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
por: Usmani, Salman Sadullah, et al.
Publicado: (2020)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide
por: Vanderheijden, Nathalie, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Specific Antibodies in Saliva Samples
por: Yu, Siyang, et al.
Publicado: (2022)

Long-Term Zidovudine Therapy and Whether It is a Trigger of Vitamin B12 Deficiency: A Case Study of Megaloblastic Anemia at the University of Zambia Teaching Hospital
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2022)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
por: Ricke, Darrell O.
Publicado: (2021)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
por: Jarlhelt, Ida, et al.
Publicado: (2021)

Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
por: Yang, Yalong, et al.
Publicado: (2022)

Antibodies to SARS-CoV-2 in follicular fluids and their association with assisted reproduction
por: Chillon, Thilo Samson, et al.
Publicado: (2023)

Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults
por: Castro, Vitória Tavares, et al.
Publicado: (2023)

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2
por: Ye, Xunyan, et al.
Publicado: (2021)

Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol
por: Zhang, Dongdong, et al.
Publicado: (2021)

Leukapheresis and Hyperleukocytosis, Past and Future
por: Zhang, Dongdong, et al.
Publicado: (2021)

The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses
por: Zhang, Lu, et al.
Publicado: (2022)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens
por: Vojdani, Aristo, et al.
Publicado: (2022)

Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies
por: Mizera, Dorota, et al.
Publicado: (2023)

Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography
por: Wang, Jiong, et al.
Publicado: (2021)

Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 Infection
por: Xiong, Bei, et al.
Publicado: (2020)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_481hom750dd4tq2di2cskrb91k